Enter a Ticker Symbol To Get Your Free Bull/Bear Rating & Ranking Report from "Stock Scientist" Mike Turner

Dividend Quote

ENDV

Endonovo Therapeutics Inc

Add to Scorecard

New Report from the Award-winning Analyst Who Beat the Market Over 15 Years

(For Privacy Policy visit us here)
*Note: You will not be spammed, ever. Period.

ENDV:Endonovo Therapeutics Inc - Stock Quote and Dividend Data

LATEST CLOSE PRICE

$0.03

EXCHANGE

OTCBB

SECTOR

Health Care

ENDV
Endonovo Therapeutics Inc Dividend Information
Trailing 12 Month Dividend Yield0.00%
Projected 10 Year Dividend Yield0.00%
Dividend Yield 5 Year Average0.00%
Dividend Rate$0.00
Dividend Payout Ratio0.00%
Dividend Payout Ratio 5 yr Average0.00%
Dividend Growth Rate 3 yr Average0.00%
Dividend Growth Rate 5 yr Average0.00%
Dividend AllStar™ Ranking
Consecutive Dividend Increases0 Years

Dividend Payment TypeNone
Dividend Declaration DateNone
Dividend Ex DateNone
Dividend Record DateNone
Dividend Pay DateNone
Dividend Amount Current$0.000
Dividend Amount Previous$0.000
Dividends Paid in the Last 12 Months0
First Dividend PaidNone

FREE INVESTOR BRIEFING

Collect an 8% Yield on this "Government Mandated Income Opportunity"

(For Privacy Policy visit us here)
*Note: You will not be spammed, ever. Period.
ENDV
Endonovo Therapeutics Inc Stock Information
Latest Close Price$0.03
52-Week Low/High$0.01 - $0.07
Percent Held by Institutions0.00%
Revenue$62,438
Net Income$-11,997,218
Cash Flow$-830,378
EPS-0.02%
Market Cap$11,178,228
PE Ratio0
PE Ratio to Industry66%
Debt-Equity Ratio999,999.00%
Debt-Equity to Industry1.38%
Total Return Last 12 Months-50.37%
Total Return Last 3 Years-91.43%
Total Return Last 5 Years0.00%
Latest Trade DateJan. 18, 2019
ENDV
Endonovo Therapeutics Inc Dividend Payment History

No Data available for Payment History.

ENDV
Endonovo Therapeutics Inc Other Details

Endonovo Therapeutics is a biotechnology company developing bioelectronic devices and cell therapies for regenerative medicine. Co.'s immunotronics platform is a non-implantable, non-invasive medical device that Co. is developing to target inflammatory conditions in vital organs. Co.'s concentration is to develop a therapeutic pipeline targeting vascular diseases and ischemia/reperfusion injuries, such as ischemic heart disease and peripheral vascular disease. Co.'s second platform is cytotronics, which is for the creation of cell-based therapies. Co.'s concentration is on the development of a cell-based treatment for graft-versus-host disease.

Web Site 
SectorHealth Care
SegmentPharmaceuticals & Biotechnology
IndustryBiotechnology
Dividend AllStar™ Ranking
Dividend Re-Investment PlanNo
Re-Investment AgentNone
Direct Purchase Minimum$0
Optional Cash Pay Min-Max$0 - $0
Optional Cash Payment FrequencyNone
Dividend Tools

Building a successful dividend income portfolio is simple… if you have the right tools at your disposal. Here’s a sampling of Dividend Investor’s Dividend Tools, used by thousands of investors across the globe to gain a substantial edge in their portfolio strategies.

Dividend AllStar™ Ranking

Find stocks with consecutively increasing dividends:

  • = 5 years of dividend increases
  • = 10 years of dividend increases
  • = 20 years of dividend increases

Click to Learn More

Monthly Dividend Directory

Learn which investments pay out every month, including:

  • Dividend yield
  • Ex-dividend date
  • Dividend payout date… and more

Click to Learn More

Stock Screening Tools

Screen and filter thousands of dividend-paying investments with Dividend Investor’s advanced screening tools:

  • Dividend Payout Ratio
  • Consecutive Increases
  • 5-Year Total Return… and more

Click to Learn More

Try Dividend Investor PREMIUM for as low as $29

  • Dividend Allstars™ Tool
  • Proprietary Ex-dividend Calendar
  • Dividend Scorecard™ Portfolio Tracker
  • Customized Dividend Stock Screener
  • 4 FREE special reports from leading dividend experts
  • And much more...
 
Endonovo Therapeutics Inc Dividend Stock News and Updates

Jan. 16, 2019CLOSE PRICE DECREASE: Endonovo Therapeutics Inc (OTCBB: ENDV) on 01-16-2019 decreased close price > 10% from $0.04 to $0.03

Read more...

Jan. 15, 2019CLOSE PRICE INCREASE: Endonovo Therapeutics Inc (OTCBB: ENDV) on 01-15-2019 increased close price > 10% from $0.03 to $0.04

Read more...

Jan. 12, 2019CLOSE PRICE INCREASE: Endonovo Therapeutics Inc (OTCBB: ENDV) on 01-12-2019 increased close price > 10% from $0.02 to $0.03

Read more...
More Endonovo Therapeutics Inc Dividend News
Biotechnology Dividend Stock News and Updates

Jan. 19, 2019CLOSE PRICE INCREASE: Affymax Inc (OTCBB: AFFY) on 01-19-2019 increased close price > 10% from $0.02 to $0.02

Read more...

Jan. 19, 2019CLOSE PRICE DECREASE: AVAX Technologies, Inc. (OTCBB: AVXT) on 01-19-2019 decreased close price > 10% from $0.00 to $0.00

Read more...

Jan. 19, 2019CLOSE PRICE DECREASE: Eurotech Ltd. (OTCBB: EUOT) on 01-19-2019 decreased close price > 10% from $0.00 to $0.00

Read more...
More Biotechnology Dividend News
X

Search Dividend Investor